Abstract:Background/Purpose Age-associated B cells (ABCs) accumulate and contribute to the pathogenesis of systemic autoimmune diseases like lupus. Despite recent insights into the ontogeny and function of ABCs, the key transcriptional regulators of ABCs differentiation remain ill-defined. Addressing this gap in knowledge will reveal targets to enable the prevention or reduction of ABCs in disease therapy. Methods We employed single-cell RNA sequencing to identify transcription factors (TFs) that were differentially expressed in age-associated B cells (ABCs) from both lupus patients and lupus-prone mice. An arrayed CRISPR screen of these regulatory TFs was conducted under in-vitro conditions that induce ABC formation. In our cohort, we included patients diagnosed with Mowat-Wilson Syndrome (MWS), a condition attributed to ZEB2 haploinsufficiency. We constructed B-cell-specific Zeb2 knockout mice and subjected them to TLR7-driving and Bm12-transfer lupus models, enabling us to study Zeb2's regulatory role in ABC formation and associated autoimmunity. The detection of autoantibodies was achieved using an autoantigen microarray. To investigate Zeb2's direct targets, we performed ATAC-seq, Cut & Tag, and Cut & Run sequencing, and integrated these regulome findings with transcriptome data obtained from RNA sequencing. We employed trans-well and PHrodo staining techniques to study the distinct migratory and phagocytic features of ABCs. The induced lupus models were used to evaluate the potential of the JAK1/3 inhibitor tofacitinib in intervening with ABC formation and associated autoimmunity. Results We carried out a screening process and identified that Zeb2 is required for in-vitro differentiation of ABCs in both humans and mice. We observed a reduction in ABCs in individuals with ZEB2 haploinsufficiency and in mice devoid of Zeb2 in B-cells (figure 1). By utilizing mice that selectively lack Zeb2 in B cells, we demonstrated the essential role of Zeb2 in facilitating autoimmune pathology relevant to ABCs, including autoantibody formation, production of proinflammatory cytokines and chemokines, migration to end- organ tissues, and induction of tissue damage in a lupus model (figure 1). Zeb2 binds to the +20kb intronic enhancer of Mef2b, thereby repressing Mef2b-mediated germinal center B-cell differentiation and instead promoting ABC formation (figure 2). Zeb2 also targets genes crucial for ABC specification and function, including Itgax (figure 2). Furthermore, Zeb2 regulates the distinct cellular characteristics of ABCs, including their migration and phagocytic abilities. The differentiation of ABCs driven by Zeb2 necessitates Jak-Stat signaling. Notably, we found that the use of tofacitinib, an approved JAK1/3 inhibitor, effectively reduces the accumulation of ABCs in autoimmune mice and patients (figure 3). Conclusion Our study reveals that ABCs, a unique B cell subset, rely on Zeb2 expression and regulation. Zeb2 affects germinal center B cell development and dictates ABC identity. Modulating Zeb2-mediated Jak-Stat signaling could effectively curb ABC accumulation and related autoimmunity, presenting a potential therapy for autoimmune diseases.

EAF2 Mediates Germinal Centre B-cell Apoptosis to Suppress Excessive Immune Responses and Prevent Autoimmunity.

EAF2 Deficiency Attenuates Autoimmune Disease in Faslpr Mice by Modulating B Cell Activation and Apoptosis

Role of EFNB1 and EFNB2 in Mouse Collagen-Induced Arthritis and Human Rheumatoid Arthritis.

Transcription factor E2F1 suppresses dendritic cell maturation.

Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice.

E2F2 directly regulates the STAT1 and PI3K/AKT/NF-κB pathways to exacerbate the inflammatory phenotype in rheumatoid arthritis synovial fibroblasts and mouse embryonic fibroblasts

ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor Β Signaling Through a Direct Interaction with Smad3*

EGR2 deletion displays similar and differential effects on immunological development and function in autoinflammation-prone B6/lpr and normal B6 mice

Two Major Genes Associated with Autoimmune Arthritis, Ncf1 and Fcgr2b, Additively Protect Mice by Strengthening T Cell Tolerance.

Role of DAF in Protecting Against T-Cell Autoreactivity That Leads to Experimental Autoimmune Uveitis

Control of germinal center B cell survival and IgE production by an adaptor molecule containing PH and SH2 domains, Aps/Sh2b2

Etanercept Attenuates Collagen-Induced Arthritis by Modulating the Association Between BAFFR Expression and the Production of Splenic Memory B Cells.

EGR2 Deletion Suppresses Anti-DsDNA Autoantibody and IL-17 Production in Autoimmune-Prone B6/lpr Mice: A Differential Immune Regulatory Role of EGR2 in B6/lpr Versus Normal B6 Mice

Crucial Role for TNF Receptor-Associated Factor 2 (TRAF2) in Regulating NFκB2 Signaling That Contributes to Autoimmunity.

Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.

EEF1B2 regulates the proliferation and apoptosis of human spermatogonial stem cell lines through TAF4B

204 ZEB2 Acts As a Crucial Transcriptional Regulator Governing Age- Associated B Cell Formation and Pathogenicity in Systemic Lupus Erythematosus

EAF2 Downregulation Recruits Tumor-associated Macrophages in Prostate Cancer Through Upregulation of MIF

The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells

AIM2 in Regulatory T Cells Restrains Autoimmune Diseases.

Lymphotoxin Pathway-Directed, Autoimmune Regulator-Independent Central Tolerance to Arthritogenic Collagen